Search Results 301-310 of 14889 for alt

1. A Study to Evaluate Itacitinib for Low Risk Graft-vs-Host Disease (GVHD) - Mayo Clinic

   ALT/SGPT and AST/SGOT must be < 5 x the upper limit of the normal range within 3 days prior to enrollment. Signed and dated written informed consent ...

2. Study to Assess Safety and Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid - Mayo Clinic

   ALT > 3 x ULN. Total bilirubin > 1 x ULN. Planned or current plasmapheresis or other extra-corporeal treatments (e.g., molecular adsorbent recirculation ...

3. A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD) - Mayo Clinic

   Abnormal liver function tests including ALT and AST, > 1.2 × ULN. Parents with renal cystic disease. Need for chronic diuretic use. Cannot be monitored for ...

4. Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis - Mayo Clinic

   ALT >3 times upper limit of normal (ULN) or AST >5 times ULN during screening. Initiation or discontinuation of non-selective beta blockers within 1 month ...

5. Intensity-Modulated Radiation Therapy and Paclitaxel with or without Pazopanib Hydrochloride in Treating Patients with Anaplastic Thyroid Cancer - Mayo Clinic

   Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) < 2.5 x institutional ULN ; note: patients who have both bilirubin > ULN and AST/ALT ...

6. Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET) - Mayo Clinic

   ST and ALT ≤ 2 x upper limit of normal; No known PNH (paroxysmal nocturnal hemoglobinuria) clone; No concurrent hormonal oral contraceptive use. Exclusion ...

7. Study Of GI-102 And PD-1 In Glioblastoma - Mayo Clinic

   Aspartate transaminase (AST) AND alanine transaminase (ALT) ≤2.5 x ULN. Amylase and lipase ≤ULN. The following test values obtained ≤29 days prior to ...

8. Enhancing the Natriuretic Peptide System in HFpEF - Mayo Clinic

   * ALT \> 2 times the upper limit of normal; * serum sodium of \< 135 mEq/dL or \> 160 mEq/dL. * Serum potassium of \< 3.5 mEq/dL or \> 5.7 mEq/dL. * Other ...

9. Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia - Mayo Clinic

   ... [ALT]) < 2.5 times ULN for age; Shortening fraction ≥ 27% by echocardiogram or ejection fraction ≥ 50% by gated radionuclide study; No evidence of dyspnea at ...

10. A Study to Evaluate the Safety and Effectiveness of DCR-PHXC to Treat Patients with Primary Hyperoxaluria Type 1 or 2 and Severe Renal Impairment - Mayo Clinic

    Liver function test abnormalities: ALT and/or AST >1.5 × ULN for age and gender. Positive anti-double-stranded deoxyribonucleic acid (anti-dsDNA) antibody ...